D-serine ammonia-lyase
D-serine ammonia-lyase[edit | edit source]
Crystal structure of D-serine ammonia-lyase.
D-serine ammonia-lyase is an enzyme that plays a crucial role in the metabolism of D-serine, an important amino acid in various biological processes. It catalyzes the conversion of D-serine to pyruvate and ammonia, thereby participating in the degradation pathway of D-serine.
Structure[edit | edit source]
The crystal structure of D-serine ammonia-lyase has been extensively studied, revealing important insights into its mechanism and function. The enzyme is composed of multiple subunits, typically arranged in a barrel-like structure. Each subunit contains a catalytic site responsible for the enzymatic activity.
Function[edit | edit source]
D-serine ammonia-lyase is primarily involved in the catabolism of D-serine, which is an essential component of various physiological processes, including neurotransmission and neuronal development. By converting D-serine to pyruvate and ammonia, this enzyme helps regulate the levels of D-serine in the body, ensuring proper functioning of these processes.
Role in Neurotransmission[edit | edit source]
D-serine is a co-agonist of the N-methyl-D-aspartate (NMDA) receptor, a subtype of glutamate receptor involved in synaptic plasticity and learning. D-serine ammonia-lyase plays a crucial role in maintaining the appropriate levels of D-serine in the brain, thereby modulating NMDA receptor activity and neurotransmission. Dysregulation of D-serine metabolism has been implicated in various neurological disorders, including schizophrenia and Alzheimer's disease.
Clinical Significance[edit | edit source]
The dysregulation of D-serine metabolism and the activity of D-serine ammonia-lyase have been linked to several neurological and psychiatric disorders. For example, decreased levels of D-serine have been observed in the brains of individuals with schizophrenia, suggesting a potential role in the pathophysiology of the disease. Additionally, alterations in D-serine metabolism have been implicated in neurodegenerative disorders such as Alzheimer's disease.
References[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
